{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:13:15Z","timestamp":1792181595872,"version":"4.4.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170151"],"award-info":[{"award-number":["82170151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2018-35-2003"],"award-info":[{"award-number":["Z-2018-35-2003"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300420238"],"award-info":[{"award-number":["232300420238"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan provincial Medical Science and Technology Research Project","award":["LHGJ20210185"],"award-info":[{"award-number":["LHGJ20210185"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421507"],"award-info":[{"award-number":["242300421507"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Province Outstanding Young and Middle-aged Talents Cultivation Project for Health Science and Technology Innovation","award":["JQRC2023009"],"award-info":[{"award-number":["JQRC2023009"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background and aim<\/jats:title>\n<jats:p>Mucormycosis is a life-threatening invasive fungal infection. This study aimed to analyze the clinical characteristics of patients with hematologic malignancies complicated with mucormycosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This retrospective study investigated the clinical characteristics, epidemiological features, treatment, and prognosis of 46 patients with hematological diseases and Mucor infection as indicated by mNGS from August 28, 2020 to September 11, 2023. Metagenomic next-generation sequencing (mNGS) refers to the application of high-throughput sequencing technology for the comprehensive analysis of nucleic acid content in patient samples, facilitating the detection and characterization of microbial DNA and\/or RNA, and then comparing and analyzing the results with an information database to determine the types of pathogenic microorganisms present in the sample.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The median age of admission for the included patients was 49 years (9\u201378). Multivariate analysis identified age over 60 years (p\u2009=\u20090.006\u2009&lt;\u20090.05), high-dose corticosteroids (p\u2009=\u20090.001\u2009&lt;\u20090.05), neutropenia lasting more than 10 days (p\u2009=\u20090.041\u2009&lt;\u20090.05), and two or more Mucor infections (p\u2009=\u20090.004\u2009&lt;\u20090.05) were independent risk factors for OS in patients with hematological diseases. Moreover, differences between groups were analyzed using the Fisher exact probability method, and no significant difference was observed in the efficacy of various types of antifungal therapies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Patients with hematologic malignancies benefit greatly from early diagnosis and treatment when suspected of Mucor infection. mNGS is an important supplementary method for early diagnosis of Mucor infection. Moderated use of corticosteroids, reducing the duration of neutropenia, and enhancing autologous immune function are important measures to reduce patient mortality rate.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0013531","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:35:17Z","timestamp":1758908117000},"page":"e0013531","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hematological diseases-related mucormycosis: A retrospective single center study"],"prefix":"10.1371","volume":"19","author":[{"given":"Yu","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-0837","authenticated-orcid":true,"given":"Xudong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"pntd.0013531.ref001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2009.02972.x","article-title":"The ecology of the Zygomycetes and its impact on environmental exposure","author":"M Richardson","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"pntd.0013531.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"OA Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0013531.ref003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"W Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"pntd.0013531.ref004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(18)30030-9","article-title":"Advances in the diagnosis and treatment of fungal infections of the CNS","volume":"17","author":"S Schwartz","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"pntd.0013531.ref005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/clinchem\/hvab173","article-title":"The Role of Metagenomics and Next-Generation Sequencing in Infectious Disease Diagnosis","volume":"68","author":"S Miller","year":"2021","journal-title":"Clin Chem"},{"key":"pntd.0013531.ref006","doi-asserted-by":"crossref","first-page":"1089196","DOI":"10.3389\/fcimb.2023.1089196","article-title":"Mucor indicus caused disseminated infection diagnosed by metagenomic next-generation sequencing in an acute myeloid leukemia patient: A case report","volume":"13","author":"M Shen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pntd.0013531.ref007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global Epidemiology of Mucormycosis","volume":"5","author":"H Prakash","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"9","key":"pntd.0013531.ref008","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006","volume":"15","author":"D Bitar","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"pntd.0013531.ref009","article-title":"Epidemiology and clinical manifestations of mucormycosis","author":"G Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pntd.0013531.ref010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cmi.2016.01.005","article-title":"Mucormycosis in Australia: contemporary epidemiology and outcomes","volume":"22","author":"KJ Kennedy","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"pntd.0013531.ref011","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"MM Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0013531.ref012","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","article-title":"Mucormycosis","volume":"35","author":"JM Steinbrink","year":"2021","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"pntd.0013531.ref013","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"JP Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pntd.0013531.ref014","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"FM Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"pntd.0013531.ref015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"G Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"pntd.0013531.ref016","doi-asserted-by":"crossref","first-page":"960766","DOI":"10.3389\/fcimb.2022.960766","article-title":"Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing","volume":"12","author":"Q Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pntd.0013531.ref017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12879-024-09236-w","article-title":"Comparison of metagenomic next-generation sequencing and conventional culture for the diagnostic performance in febrile patients with suspected infections","volume":"24","author":"H Yang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"pntd.0013531.ref018","doi-asserted-by":"crossref","first-page":"567615","DOI":"10.3389\/fcimb.2020.567615","article-title":"Improving Pulmonary Infection Diagnosis with Metagenomic Next Generation Sequencing","volume":"10","author":"Y-Y Qian","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pntd.0013531.ref019","doi-asserted-by":"crossref","first-page":"2000792","DOI":"10.1002\/smtd.202000792","article-title":"High-Throughput Metagenomics for Identification of Pathogens in the Clinical Settings","volume":"5","author":"N Li","year":"2021","journal-title":"Small Methods"},{"issue":"10","key":"pntd.0013531.ref020","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-0691.2012.03908.x","article-title":"Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008)","volume":"18","author":"A Xhaard","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"pntd.0013531.ref021","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s15010-018-1149-x","article-title":"Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome","volume":"46","author":"J Feng","year":"2018","journal-title":"Infection"},{"issue":"1","key":"pntd.0013531.ref022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11046-021-00598-2","article-title":"IFN-\u03b3 Mediated Signaling Improves Fungal Clearance in Experimental Pulmonary Mucormycosis","volume":"187","author":"AR Dos Santos","year":"2022","journal-title":"Mycopathologia"},{"issue":"3","key":"pntd.0013531.ref023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/1040841X.2022.2052795","article-title":"The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19","volume":"49","author":"S Dwivedi","year":"2023","journal-title":"Crit Rev Microbiol"},{"issue":"2","key":"pntd.0013531.ref024","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/AAC.01124-08","article-title":"Posaconazole mono- or combination therapy for treatment of murine zygomycosis","volume":"53","author":"AS Ibrahim","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"pntd.0013531.ref025","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/cid\/cis749","article-title":"Invasive mold infections following combat-related injuries","volume":"55","author":"T Warkentien","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pntd.0013531.ref026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1439-0507.2006.01299.x","article-title":"Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia","author":"V Rickerts","year":"2006","journal-title":"Mycoses"},{"issue":"7","key":"pntd.0013531.ref027","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1128\/AAC.00313-13","article-title":"Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis","volume":"57","author":"G Luo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"pntd.0013531.ref028","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1182\/blood-2011-07-366526","article-title":"Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients","volume":"118","author":"L Potenza","year":"2011","journal-title":"Blood"},{"issue":"1","key":"pntd.0013531.ref029","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/infdis\/jis308","article-title":"Characterization of the cellular immune responses to Rhizopus oryzae with potential impact on immunotherapeutic strategies in hematopoietic stem cell transplantation","volume":"206","author":"S Schmidt","year":"2012","journal-title":"J Infect Dis"},{"key":"pntd.0013531.ref030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clim.2018.11.002","article-title":"Natural and modified IL-2 for the treatment of cancer and autoimmune diseases","volume":"206","author":"M Mizui","year":"2019","journal-title":"Clin Immunol"},{"issue":"7","key":"pntd.0013531.ref031","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/428503","article-title":"Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes","volume":"191","author":"C Gil-Lamaignere","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"pntd.0013531.ref032","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw444","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"TF Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0013531.ref033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","article-title":"Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis","volume":"17","author":"D Grimaldi","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"pntd.0013531.ref034","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"M Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"pntd.0013531.ref035","volume-title":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines","year":"2021"},{"issue":"7","key":"pntd.0013531.ref036","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"M Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"pntd.0013531.ref037","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/cid\/ciab726","article-title":"Coronavirus Disease 2019-Associated Mucormycosis: Risk Factors and Mechanisms of Disease","volume":"74","author":"S Narayanan","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pntd.0013531.ref038","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/jof9060667","article-title":"Invasive Fungal Infections Associated with COVID-19","volume":"9","author":"KM Hlaing","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"pntd.0013531.ref039","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/iai.38.1.292-297.1982","article-title":"Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro","volume":"38","author":"RD Diamond","year":"1982","journal-title":"Infect Immun"},{"issue":"6","key":"pntd.0013531.ref040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/QCO.0000000000000008","article-title":"Update on mucormycosis pathogenesis","volume":"26","author":"AS Ibrahim","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"pntd.0013531.ref041","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI111395","article-title":"Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus","volume":"74","author":"AR Waldorf","year":"1984","journal-title":"J Clin Invest"},{"issue":"9","key":"pntd.0013531.ref042","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/597615","article-title":"Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis","volume":"199","author":"GA Lamaris","year":"2009","journal-title":"J Infect Dis"},{"issue":"4","key":"pntd.0013531.ref043","doi-asserted-by":"crossref","first-page":"102169","DOI":"10.1016\/j.dsx.2021.06.006","article-title":"Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit","volume":"15","author":"B Mulakavalupil","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"pntd.0013531.ref044","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"AK Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"pntd.0013531.ref045","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"DP Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0013531.ref046","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/myc.12862","article-title":"Invasive mucormycosis in children with cancer: A retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association","volume":"62","author":"P Muggeo","year":"2019","journal-title":"Mycoses"},{"key":"pntd.0013531.ref047","article-title":"Pathogenesis of mucormycosis","author":"AS Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pntd.0013531.ref048","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1148\/rg.2020190156","article-title":"Pulmonary Mucormycosis: Risk Factors, Radiologic Findings, and Pathologic Correlation","volume":"40","author":"R Agrawal","year":"2020","journal-title":"Radiographics"},{"issue":"2","key":"pntd.0013531.ref049","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/iai.38.2.487-495.1982","article-title":"Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro","volume":"38","author":"RD Diamond","year":"1982","journal-title":"Infect Immun"},{"issue":"2","key":"pntd.0013531.ref050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"G Chamilos","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pntd.0013531.ref051","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1128\/AAC.01018-07","article-title":"Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors","volume":"52","author":"M Simitsopoulou","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0013531.ref052","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1742-1241.2006.01145.x","article-title":"Mucormycosis-associated fungal infections in patients with haematologic malignancies","volume":"63","author":"IO Kara","year":"2009","journal-title":"Int J Clin Pract"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:35:25Z","timestamp":1758908125000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013531"}},"subtitle":[],"editor":[{"given":"Ahmed Hassan","family":"Fahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013531","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}